OnLux Light Therapy

Disclaimer:

The information on this website about OnLux, infrared/red light therapy, is for general knowledge only and does not constitute professional medical advice, diagnosis, or treatment. OnLux is not intended to diagnose, treat, cure, or prevent any disease.

OnLux is an FDA-registered infrared heating device (product code ILY) classified under 21 CFR § 890.5500 as an infrared lamp for medical purposes. It emits energy at infrared frequencies to provide topical heating. FDA registration link: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=692825&lpcd=ILY

Intended Uses (per FDA classification) OnLux is designed to:

• Provide temporary relief for minor muscle and joint pain, arthritis, and muscle spasms.
• Relieve stiffness. 
• Promote muscle tissue relaxation.
• Temporarily increase local blood circulation in the treated area.

OnLux does not claim to cure any specific musculoskeletal injuries or conditions. A licensed physician should always assess the nature of your injury or condition and determine if OnLux is appropriate for your treatment plan.

General Precautions

• Always consult a licensed physician before using OnLux or any light therapy device, especially if you have underlying health conditions, are pregnant, or are taking medications.
• OnLux is made with a small amount of neoprene material and is manufactured in Mexico.
• OnLux is a prescription medical device (Rx) registered with the FDA.
• Do not use OnLux if you have contraindications such as photosensitivity, certain medications (e.g., photosensitizing drugs), active cancer (without physician clearance), or epilepsy, or other conditionsconsult a physician first.
• Red light/infrared therapy is generally considered safe for most people when used as directed, but individual results vary.

Regarding Platelet-Rich Plasma (PRP) Therapy PRP therapy uses a concentration of your own platelets, derived from your blood, to promote healing, often for musculoskeletal injuries or joint rejuvenation.

• PRP and red light/infrared therapy (such as that provided by OnLux) are generally considered compatible and potentially synergistic.
• Both approaches support natural healing and tissue regeneration (e.g., via growth factors in PRP and cellular stimulation from light therapy), without the suppressive effects seen with steroids.
• Many practitioners and studies view this combination as beneficial for enhanced recovery in joint or soft-tissue applications.
• However, this is not medical advicealways consult your healthcare provider to confirm suitability for your specific situation, timing, and protocol.

Regarding Corticosteroid (Steroid) Injections or Oral Steroids (e.g., Cortisone)

• Most sources recommend a waiting period of at least one week (710 days) after receiving a cortisone/steroid injection or starting oral steroids before beginning or resuming red light/infrared therapy.
• This precaution allows the steroid to exert its intended suppressive/anti-inflammatory effects without potential interference. Steroids suppress immune and inflammatory responses, while light therapy may stimulate cellular activity and natural healing pathways potentially counteracting each other.
• Some evidence from studies and clinical guidelines suggests that concomitant use of steroids and low-level light therapy could reduce the anti-inflammatory benefits of the therapy or interfere with steroid efficacy.
• Always consult your healthcare provider (e.g., doctor or specialist) before combining OnLux/red light therapy with any steroid treatment, as individual factors like dosage, timing, and health conditions matter.

Final Recommendation
We strongly recommend discussing the use of OnLux or any light therapy with your doctor or qualified healthcare professional, especially if you have recent injections, are on medications, or have underlying health conditions. Your provider can offer personalized guidance based on your medical history.